Skip to content
Manufacturing, Medical Health Aged Care

Microban launches Ascera(TM): a patent-pending, cutting-edge antimicrobial technology inspired by nature

Microban International 2 mins read

Huntersville, NC Microban International is pleased to introduce its latest ground-breaking technology – Ascera™. This patent-pending, next generation antimicrobial technology uses an active ingredient inspired by nature*, and is designed for use in olefinic polymers and solvent-based coatings. Ascera is sustainable, metal free and less toxic than alternative technologies, and provides the lifelong antimicrobial product protection that Microban is known for around the world.

As the global leader in antimicrobial and odor-control technologies, Microban is committed to the development of solutions that support product sustainability by extending their useful lifetimes. Ascera exemplifies the company’s commitment to sustainability by offering lasting product protection while maintaining critical attributes, such as ease of incorporation, safe handling, and good chemical, thermal and UV stability. Ascera will perform for the product’s expected lifetime when applied according to Microban’s standards, effectively inhibiting the growth of odor-causing bacteria to prevent stains and premature aging of the finished product.

“Microban has always led the antimicrobial industry with technological innovations that contribute to product sustainability,” said Dr. Souvik Nandi, Vice President of R&D at Microban International. “In the past decade, regulatory and environmental groups have put increasing pressure on many of the antimicrobial chemistries that are currently used. As a result, Microban has invested significant resources in identifying naturally occurring solutions that are more sustainable and effective. We are very proud to roll out Ascera, which represents the culmination of many years of intensive research. This is the first of an exciting series of nature-inspired solutions that we will be launching in the next few years for different market segments and material types.”

“As the global leader in antimicrobial, odor-control and surface modification solutions, Microban is always standing at the forefront of the industry. As we work towards our vision of becoming the most trusted brand in ultimate cleanliness and product protection, we want the world to rely on Microban for best-in-class solutions.” Michael Ruby, President of Microban International, said. “Our R&D teams are laser-focused on developing a range of cutting-edge technologies that are nature inspired for the different market sectors we serve. Our partners look to us first for what is next. Ascera will help leading brands to create clean, odor-free and high value end-use products, which their customers will choose to support sustainability and live a clean and refreshing lifestyle."

Ascera is available to manufacturers in the U.S. and Asia, along with Microban’s support and expertise. Find out more at https://www.microban.com/antimicrobial-solutions/technologies/ascera and get in touch with a representative today!

*The Microban® technology used in this product is similar to acids found in nature and is used in multiple consumer product applications.


About us:

Company Website

https://www.microban.com/


Contact details:

Audrey Jestin at kdm communications limited,

St Neots, UK

+44 1480 405333

ideas@kdm-communications.com

More from this category

  • Medical Health Aged Care
  • 18/10/2024
  • 10:22
Royal Australian College of GPs

‘Fantastic milestone’ for 88 new specialist GPs in South Australia

The Royal Australian College of GPs will welcome 88 new fellows as specialist GPs in South Australia at a ceremony on Saturday 19 October, which will also celebrate the state’s annual RACGP Award winners. The new GPs attending the event in Adelaide Town Hall will include eight rural generalists – GPs who’ve completed Additional Rural Skills Training in fields such as anaesthesia and obstetrics. Fellowship of the RACGP (FRACGP) reflects a doctor’s qualification and expertise as a specialist GP and is the culmination of around 11 years of education, training, rigorous assessment, and experience in primary care. RACGP President Dr…

  • Medical Health Aged Care, Science
  • 18/10/2024
  • 09:30
Centenary Institute

Revealing the role of immune cells in liver cancer

New research from the Centenary Institute and the University of Sydney has uncovered important insights into the immune environment within liver cancer, the sixth…

  • Contains:
  • Medical Health Aged Care
  • 18/10/2024
  • 06:35
Royal Australian College of GPs

ACT Labor’s proposed walk-in centres expansion leaves cost and care questions unanswered: RACGP

The Royal Australian College of GPs (RACGP) has reiterated its call for the next ACT government to commit to an independent evaluation of the ACT nurse-led walk-in centres. With ACT Labor announcing an expansion of centres which are reportedly bleeding taxpayers’ money, ahead of this Saturday’s election, the RACGP also gave its assessment of parties’ primary care policies. An independent evaluation of the centres has been a core pillar of the RACGP’s ACT election platform since before a Canberra Times investigation revealed health officials had “buried” $10 million in expenses. Emails obtained under a Canberra Times freedom of information request…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.